EAM
Eagle Asset Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
41.7%
1 Year Est. Return
+41.7%
AUM
$18.6B
AUM Growth
-$1.1B
(-5.6%)
Holding
605
Top Buys
| 1 | +$127M | |
| 2 | +$102M | |
| 3 | +$81.2M | |
| 4 |
Natera
NTRA
|
+$78.1M |
| 5 |
Nutanix
NTNX
|
+$71.4M |
Top Sells
| 1 | +$138M | |
| 2 | +$136M | |
| 3 | +$134M | |
| 4 |
IQVIA
IQV
|
+$106M |
| 5 |
Global Payments
GPN
|
+$95.8M |
Sector Composition
| 1 | Technology | 26.13% |
| 2 | Industrials | 16.27% |
| 3 | Healthcare | 15.43% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Financials | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
TD Synnex
SNX
$12.4B
| $4.66M | 0.03% |
40,887
+15,369
|
|
||
402
Watsco Inc
WSO
$14B
| $4.61M | 0.02% |
9,988
-1,449
|
|
||
403
CACI
CACI
$13.6B
| $4.6M | 0.02% |
10,755
-1,534
|
|
||
404
Disc Medicine
IRON
$3.52B
| $4.59M | 0.02% |
98,675
-17,063
|
|
||
405
Allient
ALNT
$913M
| $4.57M | 0.02% |
187,556
-441
|
|
||
|
CCC
406
CCC Intelligent Solutions
CCC
$4.77B
| $4.56M | 0.02% |
+410,592
|
|
||
407
Lam Research
LRCX
$196B
| $4.56M | 0.02% |
42,960
+5,420
|
|
||
408
United Airlines
UAL
$33B
| $4.41M | 0.02% |
91,322
+5,251
|
|
||
409
Arch Capital
ACGL
$34.1B
| $4.34M | 0.02% |
43,094
+1,106
|
|
||
410
Progressive
PGR
$134B
| $4.25M | 0.02% |
20,278
+8,422
|
|
||
411
Ameriprise Financial
AMP
$42.3B
| $4.24M | 0.02% |
9,946
+245
|
|
||
412
ODP
ODP
$842M
| $4.07M | 0.02% |
103,471
-1,110
|
|
||
413
Northern Oil and Gas
NOG
$2.19B
| $4.05M | 0.02% |
107,473
-10,595
|
|
||
414
Phathom Pharmaceuticals
PHAT
$1.11B
| $3.91M | 0.02% |
361,463
+56,624
|
|
||
|
LGTY
415
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $3.9M | 0.02% |
429,979
-7,701
|
|
||
416
Taysha Gene Therapies
TSHA
$1.3B
| $3.89M | 0.02% |
1,722,586
-66,808
|
|
||
417
Trane Technologies
TT
$93.5B
| $3.88M | 0.02% |
12,083
+5,896
|
|
||
418
AptarGroup
ATR
$8.19B
| $3.87M | 0.02% |
+27,931
|
|
||
419
WEX
WEX
$5.09B
| $3.75M | 0.02% |
21,383
+1,502
|
|
||
420
Pacira BioSciences
PCRX
$1.01B
| $3.75M | 0.02% |
131,724
-559
|
|
||
421
InMode
INMD
$901M
| $3.72M | 0.02% |
208,015
-37,268
|
|
||
422
Immunocore
IMCR
$2B
| $3.71M | 0.02% |
101,964
+58,866
|
|
||
423
Exelixis
EXEL
$11.8B
| $3.7M | 0.02% |
166,193
-32,333
|
|
||
424
ConocoPhillips
COP
$110B
| $3.67M | 0.02% |
32,075
+792
|
|
||
425
Viking Therapeutics
VKTX
$4.16B
| $3.62M | 0.02% |
65,437
-215,411
|
|